204 related articles for article (PubMed ID: 27389914)
1. Distribution and Patterns of Industry-Related Payments to Oncologists in 2014.
Marshall DC; Moy B; Jackson ME; Mackey TK; Hattangadi-Gluth JA
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27389914
[TBL] [Abstract][Full Text] [Related]
2. Types and Distribution of Payments From Industry to Physicians in 2015.
Tringale KR; Marshall D; Mackey TK; Connor M; Murphy JD; Hattangadi-Gluth JA
JAMA; 2017 May; 317(17):1774-1784. PubMed ID: 28464140
[TBL] [Abstract][Full Text] [Related]
3. Examination of Industry Payments to Radiation Oncologists in 2014 Using the Centers for Medicare and Medicaid Services Open Payments Database.
Jairam V; Yu JB
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):19-26. PubMed ID: 26547386
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
Mitchell AP; Winn AN; Lund JL; Dusetzina SB
Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists.
Weng JK; Valle LF; Nam GE; Chu FI; Steinberg ML; Raldow AC
JAMA Netw Open; 2019 Jan; 2(1):e187377. PubMed ID: 30681710
[TBL] [Abstract][Full Text] [Related]
6. Industry Funding Among Leadership in Medical Oncology and Radiation Oncology in 2015.
Yoo SK; Ahmed AA; Ileto J; Zaorsky NG; Deville C; Holliday EB; Wilson LD; Jagsi R; Thomas CR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):280-285. PubMed ID: 28366578
[TBL] [Abstract][Full Text] [Related]
7. Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019.
Tarras ES; Marshall DC; Rosenzweig K; Korenstein D; Chimonas S
JAMA Oncol; 2021 Mar; 7(3):440-444. PubMed ID: 33377904
[TBL] [Abstract][Full Text] [Related]
8. Industry Funding Is Correlated With Publication Productivity of US Academic Radiation Oncologists.
Zaorsky NG; Ahmed AA; Zhu J; Yoo SK; Fuller CD; Thomas CR; Choi M; Holliday EB
J Am Coll Radiol; 2019 Feb; 16(2):244-251. PubMed ID: 30219342
[TBL] [Abstract][Full Text] [Related]
9. Medical industry at tumor board: Three-years analysis of the open payments database and comparison of oncologic specialties.
Baadh AS; Patel M; Patel K; Ahmed O
J Surg Oncol; 2018 Mar; 117(4):551-557. PubMed ID: 29165809
[TBL] [Abstract][Full Text] [Related]
10. Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.
Rahman MW; Trivedi NU; Bach PB; Mitchell AP
J Natl Compr Canc Netw; 2021 Dec; 20(13):1-9. PubMed ID: 34965511
[TBL] [Abstract][Full Text] [Related]
11. Industry Relationships With Medical Oncologists: Who Are the High-Payment Physicians?
Wright K; Meyers DE; Chisamore TM; McInnes MDF; Sismondo S; Gyawali B; Prasad V; Booth CM
JCO Oncol Pract; 2022 Jul; 18(7):e1164-e1169. PubMed ID: 35696634
[TBL] [Abstract][Full Text] [Related]
12. Association between physician characteristics and payments from industry in 2015-2017: observational study.
Inoue K; Blumenthal DM; Elashoff D; Tsugawa Y
BMJ Open; 2019 Sep; 9(9):e031010. PubMed ID: 31542759
[TBL] [Abstract][Full Text] [Related]
13. Industry payments to US physicians for cancer therapeutics: An analysis of the 2016-2018 open payments datasets.
Meyers DE; Chisamore TM; McInnes MDF; Gyawali B; Prasad V; Booth CM
J Cancer Policy; 2021 Jun; 28():100283. PubMed ID: 35559912
[TBL] [Abstract][Full Text] [Related]
14. Trends in Financial Relationships Between Industry and Radiation Oncologists Versus Other Physicians in the United States from 2014 to 2018.
Marshall DC; Tarras ES; Rosenzweig K; Yom SS; Hattangadi-Gluth J; Murphy J; Korenstein D; Chimonas S
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):15-25. PubMed ID: 32858112
[TBL] [Abstract][Full Text] [Related]
15. Variations in Medicare Reimbursement in Radiation Oncology: An Analysis of the Medicare Provider Utilization and Payment Data Set.
Vu CC; Lanni TB; Robertson JM
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1000-5. PubMed ID: 27026306
[TBL] [Abstract][Full Text] [Related]
16. Financial Relationships With Industry of Editorial Board Members of the Three Journals of the American Society for Radiation Oncology.
Verma V
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):286-291. PubMed ID: 28871971
[TBL] [Abstract][Full Text] [Related]
17. A population-based assessment of specialty physician involvement in cancer clinical trials.
Klabunde CN; Keating NL; Potosky AL; Ambs A; He Y; Hornbrook MC; Ganz PA
J Natl Cancer Inst; 2011 Mar; 103(5):384-97. PubMed ID: 21317382
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.
Ozaki A; Saito H; Onoue Y; Sawano T; Shimada Y; Somekawa Y; Tsuji A; Tanimoto T
BMJ Open; 2019 Sep; 9(9):e028805. PubMed ID: 31494604
[TBL] [Abstract][Full Text] [Related]
19. Nature of Medical Malpractice Claims Against Radiation Oncologists.
Marshall D; Tringale K; Connor M; Punglia R; Recht A; Hattangadi-Gluth J
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):21-30. PubMed ID: 28586962
[TBL] [Abstract][Full Text] [Related]
20. Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
Mitchell AP; Mishra A; Dey P; Curry MA; Trivedi NU; Haddadin M; Rahman MW; Winn AN; Dusetzina SB; Bach PB
Oncologist; 2021 Sep; 26(9):771-778. PubMed ID: 33982829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
